Covered recipient · General Payments record
JOSEPH D SUMMERS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,021.38
- Reported across 279 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $295.40 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $71.16 | 3 |
| Novo Nordisk AS | $67.27 | 3 |
| Phathom Pharmaceuticals, Inc. | $65.39 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $55.45 | 2 |
| Amgen Inc. | $36.13 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.25 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106182070 | CMS |
| ABBVIE INC. | $16.91 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106182072 | CMS |
| ABBVIE INC. | $28.00 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106182074 | CMS |
| Amgen Inc. | $15.51 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111718739 | CMS |
| Amgen Inc. | $20.62 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111718741 | CMS |
| Novartis Pharmaceuticals Corporation | $23.99 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087332283 | CMS |
| Novartis Pharmaceuticals Corporation | $31.46 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087332275 | CMS |
| Novo Nordisk Inc | $24.75 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097461123 | CMS |
| Novo Nordisk Inc | $21.18 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097053512 | CMS |
| Novo Nordisk Inc | $21.34 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096946406 | CMS |
| Phathom Pharmaceuticals, Inc. | $33.50 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151130991 | CMS |
| Phathom Pharmaceuticals, Inc. | $31.89 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151130993 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.